Chicago Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Chicago Wealth Management's XBI Position: Q3 2026 in Review
Chicago Wealth Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 15% in Q3 2026, buying an estimated $1.91M and bringing the position to 90,790 shares worth $14.3M. The position accounts for 5.1% of the portfolio, ranked #3.
Chicago Wealth Management first reported a position in XBI in Q3 2022 and has held it in 4 quarters since. 960 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Chicago Wealth Management held 90,790 shares of State Street SPDR S&P Biotech ETF worth $14.3M as of Q3 2026.
- Chicago Wealth Management bought 12,102 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $1.91M.
- State Street SPDR S&P Biotech ETF made up 5.1% of Chicago Wealth Management's portfolio in Q3 2026, its #3 holding.
- Chicago Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 4 quarters since.
- 960 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Chicago Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.